RXi Pharmaceuticals Corp (RXII) Deals and Alliances Profile

RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer. The companys technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways in fibrosis including scar ... Read more